Exceptional Response to Trastuzumab Deruxtecan in a Patient With Recurrent Ovarian Clear Cell Carcinoma With Human Epidermal Growth Factor Receptor 2 Expression The following represents disclosure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback